Processing and assembly of bovine leukaemia virus-like particles were studied in African green monkey kidney cells using recombinant vaccinia viruses (rVVs) expressing regions of the bovine leukaemia virus genome. Unprocessed gag precursor protein (Pr44) was detected in immunoblot analysis of lysed cells and particles sedimented from culture supernatants after infection with a rVV carrying the gag and truncated protease (pro) gene. Processing of Pr44 was observed after infection of cells with a rVV carrying the gag and pro gene or a rVV expressing the gag, pro and polymerase (pol) gene. Reverse transcriptase activity was detected only in association with particles produced by gag-,pro-andpolexpressing recombinants. Thin section electron microscopic analysis of infected cells and pelleted particles revealed that Pr44 and processed gag proteins assembled at the cell membrane. Pr44 was released into the cell culture media as immature virus-like particles, whereas processed gag proteins from rVVs expressing gag andpro or gag, pro and pol formed mature particles.
Introduction
The exogenous retrovirus, bovine leukaemia virus (BLV), is the aetiological agent of enzootic bovine leukosis, which occurs worldwide. Infected cattle may develop lymphocytosis and a small number suffer from lymphosarcoma (Burny et al., 1988) . BLV and human T cell leukaemia viruses (HTLV) type I and type II constitute a unique subgroup within the family Retroviridae. The BLV gag region is similar to that of other retroviruses in that it is initially translated as a polyprotein precursor, which is subsequently cleaved to form the mature gag proteins p15, p24 and p12. Unlike most other retroviruses the protease (pro) of BLV and HTLV is not encoded within the same reading frame as the 3' end of the gag precursor or the 5' end of the polymerase (pol) gene products. It is encoded by a different reading frame, which spans the 3' part of the gag and the 5' part of the pol region (Coffin, 1990) . Protease synthesis occurs by a ribosomal frameshift suppression of the gag termination codon leading to the gag-pro precursor Pr66 (Le et al., 1991; Yoshinaka et al., 1986) . Similarly, expression of the pol gene products, reverse transcriptase (RT) and integrase, may also involve a ribosomal frameshift shortly before the termination codon at the end of the pro region (Le et al., 1991) , thus requiring continuous translation from genetic information that is located in three different reading frames. The envelope glycoproteins gp51 and gp30, which represent the surface glycoprotein and the transmembrane components of the virus respectively, are transcribed from a spliced, subgenomic mRNA (Cann &Chen, 1990) . In contrast to other retroviruses, the BLV and HTLV genomes encode at least two non-virion proteins between the envelope (env) gene and the 3' long terminal repeat (LTR), which are transcribed from a second, double-spliced subgenomic mRNA (Rice et al., 1987; Derse, 1987) .
The formation of virus-like particles (VLPs) has been reported by several groups for other subgroups of retroviruses. Various expression systems were used to produce VLPs based on the human immunodeficiency virus (HIV) (Haffar et al., 1990; Luo et al., 1990; Smith et al., 1993) . The release of particles was also reported when bovine (Rasmussen et al., 1990) or feline (Morikawa et al., 1991) immunodeficiency virus gag proteins were expressed using baculovirus vectors and when the matrix protein of simian immunodeficiency virus was expressed by recombinant vaccinia viruses (rVV; Gonz~lez et al., 1993) or recombinant fowlpox viruses (Jenkins et al., 1991) . To our knowledge, the work in this paper is the first demonstration of the efficient formation of virus-like particles from the BLV/HTLV retrovirus subgroup. Expression and processing of the BLV gag precursor resembled that of HIV and led to the formation of mature or immature VLPs. The formation of mature and immature VLPs depended upon whether or not the BLV pro region was expressed by the rVV.
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Methods
Construction of insertion plasmids. PCR was carried out using the AmpliTaq kit (Perkin-Elmer Cetus) on plasmid pBLV-A1 containing an Australian BLV provirus isolated from a sheep tumour (Coulston et al., 1990) . Primers P599 (5' CCTAAAG_CTTCTCTGGACCCACC 3'; positions 567 to 589) and P592 (5' GCTCAAGCTTCCGCGGC-GGGGGTCCG 3'; 2063 to 2038) containing 5' mismatches (underlined), which generated HindIII sites to facilitate subcloning, were used to amplify a fragment coding for BLV Gag. The PCR product was purified by agarose gel electrophoresis followed by extraction with GeneClean (BIO 101), digested with HindIII and cloned in pUC19 to generate pCH5. pCH5 was then digested with BssHII and HindII to insert the BssHII-SspI fragment of pBLV-A1. The resulting plasmid, pCH8, contained the BLV genes gag, pro, pol and a portion of env. Removing the XbaI fragment of pCH8 yielded pCH 11, which contained the gag and pro genes and a part of the pol coding region. The pUC19 plasmids pCH5, pCH8 and pCH11 were used to subclone the gag, gag-pro-pol or gag-pro coding sequences into vaccinia virus (VV) transfer vectors pMJ602 (Davison & Moss, 1990 ) and pBCB06 (Boyle et al., 1985) . In pMJ602 the VV thymidine kinase (TK) gene is interrupted by a synthetic late promoter, PsL, and a multiple cloning site. In pBCB06 the VV P7.5 promoter followed by a multiple cloning site is inserted in the same VV TK fragment. The HindlII fragment of pCH5 was subcloned into the HindllI sites of pMJ602 and pBCB06 to generate transfer vectors for the gag gene, designated rVV-gPs~ and rVV-gPT, s respectively. HindlII EcoRI fragments were transferred from pCH8 and pCHll into HindIII-and EcoRI-digested pBCB06, yielding transfer vectors containing the gag, pro and pol genes (rVVg/P/PPT.5) and the gag and pro genes (rVV-g/pPT.5). To generate the transfer vector for rVV-g/p/pPsL, pCH8 was EcoRI-digested, filled in with the Klenow fragment of DNA polymerase and cut with HindIII. The fragment containing the BLV gag pr~pol region was then cloned into HindlII-and Sinai-digested pMJ602. Removing the BamHI fragment of this pMJ602-based vector led to the transfer vector for the gag pol region, rVV-g/pPsL.
Cells and viruses. Human TK-143B cells infected with VV strain WR L929 were used to construct rVVs by homologous recombination as described previously (Boyle et al., 1985) . These rVVs were plaquepurified three times on 143B cells, pMJ602-derived recombinants were identified by their ability to form blue plaques in the presence of X-Gal due to coexpression of fl-galactosidase (Chakrabarti et al., 1985) . Recombinants based on pBCB06 were screened by plaque hybridization with a nick-translated PCR gag fragment. A schematic representation of the BLV sequences present in the rVVs used in this study is shown in Fig. 1 . African green monkey kidney cells (CV-1) were used for expression experiments. BLV-producing fetal lamb kidney (FLK) cells were maintained according to published methods ( Van der Maaten & Miller, 1975) . All cells were grown in Eagle's minimum essential medium supplemented with 5 % fetal calf serum, 10 mM-HEPES, 100 U/ml penicillin, 100 lag/ml streptomycin and 2 mM-glutamine.
Immunoblot analysis. Monolayers of CV-1 cells grown to confluence in 25 cm 2 flasks were infected with rVVs or WR L929 at a m.o.i, of 10. At 16 h post-infection, cells were washed twice with PBS and scraped into 500 pl of SDS gel-loading buffer (50 mM-Tris-HC1 pH 6.8, 10% v/v glycerol, 2 % w/v SDS, 0.1% w/v bromophenol blue and 100 mM-DTT). BLV-producing FLK cells were used as a positive control.
Supernatants of BLV-producing FLK cells and of cells infected as described above were collected at 16 h post-infection and clarified by centrifugation at 2500 r.p.m, for 10 min. Remaining cell debris and VVs were removed by ultrafiltration through 0-2 gm filters. The resulting filtrates (6 ml) were purified by centrifugation at 35 000 r.p.m. through 4.5 ml 20% (w/v) sucrose onto 1.5 ml 60% sucrose cushions in a Beckman SW41 rotor for 2 h at 4 °C. Particles removed at the interface were diluted 1:4 with PBS and pelleted through 4.0 ml of 20 % sucrose in an SW41 rotor using the same conditions as above. The resulting pellets were resuspended in 25 ~tl of SDS gel-loading buffer.
Twenty I~1 of lysed cells or 5 gl of the lysed pelleted particles was resolved by SDS-PAGE on 12% gels and transferred onto nitrocellulose membranes (Schleicher & Schuell) by electroblotting. The membranes were blocked with 5 % non-fat powdered milk in 0.02 % Tween 20 and PBS, incubated with serum from a BLV-infected sheep for 1 h, washed three times, incubated with donkey anti-sheep antibody conjugated with horseradish peroxidase (Silenus), washed three times and reacted with 4-chloro-l-naphthol and hydrogen peroxide.
Fractionation of metabolically labelled particles. Confluent CV-1 monolayers were infected with rVVs and WR L929 as described above. At 4 h post-infection the medium was removed, cells were washed once with PBS and methionine-free medium (Flow Laboratories) supplemented with 2% fetal calf serum, 10mM-HEPES, 100 U/ml penicillin, 100 lag/ml streptomycin, 2 mM-glutamine and 1.5 gg/ml methionine (10% of normal concentration), and [z~S]methionine (greater than 1000 Ci/mmol; Amersham) at 75 ~tCi/ml was added. At 16h post-infection, 13.5~g/ml methionine was added for 1 h. Supernatants were clarified and filtered before pelleting radiolabelled particles at 40000 r.p.m, through 3 ml 20% sucrose in an SW55 rotor for 1.5 h at 4 °C. Pellets were resuspended in 200 gl of PBS and layered onto 12 ml of a 20 to 60 % sucrose gradient, then centrifuged at 35 000 r.p.m, for 2.5 h in an SW41 rotor at 4 °C. Twelve 1 ml fractions, collected from bottom to top, were each diluted 1 : 5 before pelleting at 40000 r.p.m, in an SW55 rotor for 1 h at 4 °C. Pelleted fractions were lysed with 25 pl SDS gel-loading buffer. Two gl was added to 2 ml of counting scintillant (Amersham) to determine radioactivity. Samples (20 ~tl) were separated by 12% SDS PAGE, which then were fixed, enhanced with Amplify (Amersham), dried and exposed to film.
RT assay. Supernatants from rVV-infected cell cultures and BLVproducing FLK cells were clarified and filtered as described above. Particles contained in the resulting supernatants were pelleted at 35 000 r.p.m, in a Beckman SW41 rotor for 2.5 h at 4°C. Pellets were resuspended in RT lysis buffer (30 mM-Tris-HCl pH 8"0, 80 mM-KCI, 1-0 mM-EDTA, 0.1% v/v Triton X-100, 10% v/v glycerol and 2 mM-DTT) and twofold dilution series tested for RT activity using RTdetect (NEN Du Pont) according to the manufacturer's instructions. The 4 × RT buffer used contained 130 mM-Tris-HC1 pH 8.0, 120 mM-KC1 and 33-6 mM-MgCI 2.
Supernatants of rVV-g/p/pPs~-infected cell cultures were fractionated in a 20 to 60 % sucrose gradient as described above but particles were resuspended in RT lysis buffer instead of SDS gel-loading buffer. The resulting fractions were tested for RT activity.
Electron microscopy. Thin sections of infected cells and purified VLPs and BLV were prepared for conventional electron microscopy. CV-1 cells were infected with rVVs or WR L929 at a m.o.i, of 10. BLVproducing FLK cells were used as a positive control. At 16 h postinfection the cell cultures were fixed for 40 rain with 2.5 % glutaraldehyde in 0.1 M-cacodylate buffer pH 7.2, washed three times for 20 min in the same buffer, post-fixed for 1 h in 1% osmium tetroxide (in the above buffer), dehydrated in graded ethanol and embedded in low viscosity Spurr's resin.
Supernatants of BLV-producing FLK cells and of CV-1 cells infected with rVVs as described above were clarified by centrifugation and ultrafiltration and pelleted by ultracentrifugation through 20% sucrose. The pellets were infiltrated with 5 % gelatine and processed as described above for infected cells.
Both rVV-infected CV-1 cells and BLV-producing FLK cells were also processed for pre-embedding immunogold electron microscopy. As VLPs lack surface-expressed glycoproteins it was necessary to Numbers indicate nucleotide positions according to the published sequence of the Australian BLV isolate (Coulston et al., 1990) .
permeabilize the cells, and so the limiting membrane of the VLPs, with a non-ionic detergent. Cells were fixed in cacodylate-buffered 0.1% glutaraldehyde for 2 min, washed three times for 3 min in the same buffer and permeabilized with 1% Nonidet P40 for 2 min. Cells were then washed in cacodylate buffer, incubated with the primary antibody (serum from a BLV-infected sheep) for 2 h at room temperature, washed six times for 3 min in the same buffer and incubated further with 6 nm gold-labelled rabbit anti-goat antibodies for 1 h at room temperature. Following further washing with cacodylate buffer (six times for 3 min) the cells were processed for thin sectioning as described above. Negative controls consisted of WR L929-infected cells and pelleted supernatants of WR L929-infected cell cultures.
Results
Expression and processing of BL V genes
Recombinant vaccinia viruses containing various regions of the BLV genome were constructed, expressing the BLV genes under the control of either a synthetic late promoter, PSL, or the vaccinia virus promoter P7.5 (Fig.  1) . Recombinants expressing gag proteins (rVV-g) contained the gag gene and the nucleotide sequence encoding the 99 N-terminal amino acids of pro. Recombinants expressing gag and pro (rVV-g/p) contained the gag and pro genes and 379 out of 852 amino acids encoded by the pol gene. The last recombinants (rVV-g/p/p) expressing gag, pro and pol, contained the gag, pro and pol genes and extended into the sequence encoding 225 amino acids of the gp51-coding region of the env gene. Expression of BLV gag proteins was first examined by immunoblot analysis of cell lysates. Fig. 2 (a) shows that all recombinants expressed BLV gag proteins. Consistently higher levels of expression were detected in cells infected with recombinants expressing the BLV genes under the control of the PsL promoter and therefore subsequent experiments were performed with the PsL recombinants only. The 44K gag precursor protein (Pr44) was detected in all lysates of cells infected with rVVs and lysates of BLV-producing FLK cells used as positive controls. The mature gag protein p24 appeared only in rVV-g/p-or rVV-g/p/p-infected cells. Higher M r precursors of unknown derivation and specificity were detected in all lysates but predominantly in rVV-ginfected cells. In lysates of rVV-g/p-and rVV-g/p/pinfected cells, processing intermediates with MrS of 30K to 31K and 33K to 34K were detected. These probably represented Pr44 after proteolytic cleavage between p 15 and p24 or between p24 and p12 respectively. A small amount of the 30K to 31K intermediate was also detected in rVV-g-derived cell lysates. No BLV-specific proteins were detected in WR L929-infected control cells.
Immunoblot analysis (Fig. 2b ) of virus-like particles pelleted from supernatants of cell cultures infected with rVVs revealed that the unprocessed gag precursor protein Pr44 was present in purified supernatants of only rVV-ginfected cell cultures. As in cell lysates, mature p24 was detected upon infection with rVV-g/p and rVV-g/p/p, which also expressed the pro gene, and in BLV-producing FLK cell controls. Envelope glycoprotein was detected as a diffuse band in the lane containing purified control virus (BLV from FLK cells). The number and amount of intermediates were reduced in comparison with those in cell lysates shown in Fig. 2(a) , but some appeared to be incorporated into VLPs. No BLV-specific proteins were detected in purified supernatants of WR L929-infected control cells.
Formation of VLPs
To investigate whether particles were formed or if the released proteins were coprecipitated in association with cellular material, we metabolically labelled expression products of infected cell cultures, pelleted the culture media and fractionated the resuspended pellets in a 20 to 60 % sucrose gradient. After pelleting each fraction we determined the radioactivity of a portion of the final pellet and separated the remaining proteins by SDS-PAGE. The proteins of the three different types of VLP were found in fractions of similar density, rVV-g-derived VLPs consisted only of the gag precursor protein Pr44 and a higher M r precursor of unknown identity (Fig. 3 a) . Infection with rVVs that also expressed the pro gene (rVV-g/p and rVV-g/p/p) led to the formation of particles containing the mature gag proteins p24 and p12 (Fig. 3 b and c) . The pl 5 protein contained no methionine and was therefore not detectable in these experiments.
RT activity in supernatants of r VV-infected cells
To examine expression of RT we tested pelleted supernatants of rVV and WR L929-infected cell cultures and supernatants of BLV-producing FLK cells. The RTdetect kit allowed detection of reverse-transcribed cDNA in an enzyme-linked oligonucleotide sorbent assay. No RT activity was detected in lysed particles resulting from rVV-g and rVV-g/p infections, rVV-g/p/p-derived Fig. 4 . Transmission electron micrographs of ultrathin sections from purified and gelatine-embedded VLP and BLV pellets. VLPs were purified from supernatants of cell cultures infected with rVV-g (a), rVV-g/p (b) and rVV-g/p/p (c) and BLV (d) from persistently infected FLK cells. Dense inner cores are absent in rVV-g-derived particles. Scale bars represent 100 nm. particles and F L K cell-produced BLV controls consistently yielded positive results (data not shown).
After fractionating supernatants of r V V -g / p / pinfected cell cultures in 20 to 60 % sucrose gradients, we determined the R T activity of the particles pelleted from each fraction. Positive results were obtained from fractions of the same sucrose density as those containing radiolabelled gag proteins. In Fig. 3 (c) are shown together with the radioactivity levels, and the autoradiogram of an equivalent but independent experiment.
Electron microscopy
Examination of ultrathin sections of purified and pelleted VLPs (Fig. 4) showed that they exhibited morphology similar to that of BLV. All VLPs and FLK cell-produced BLV ranged from 80 to 115 nm in diameter. With the exception of rVV-g, the VLPs possessed dense inner cores, which were surrounded by an outer membrane. rVV-g-derived particles differed in that they possessed no dense inner core and there was an increased prevalence of aberrant forms.
Examination of ultrathin sections of infected cells (Fig. 5) showed the assembly and ultrastructure of VLPs to be consistent with those of a retrovirus. All rVVinfected cells showed extracellular VLPs (Fig. 5 a, c, d , f) and budding structures resembling immature BLV at the plasma membrane (Fig. 5 b, e). Particles with condensed inner cores were observed for rVV-g/p-and rVV-g/p/pinfected cells that were indistinguishable in diameter and structure from BLV of persistently infected FLK cells (Fig. 4 and 5) . VLPs, in all rVV-infected cells, were also observed within intracellular smooth-surfaced vesicles (data not shown). Retrovirus-like particles were absent from WR L929-infected control cells (data not shown).
Immnnoelectron microscopy was used to confirm the authenticity of the VLPs. Gold-labelled BLV and retrovirus-like structures were observed in all of the infected cells (Fig. 5) . No gold-labelled structures were observed in the negative control cells (data not shown).
Discussion
We have shown in this study that the expression of BLV genes in CV-1 cells by rVV resulted in the assembly and release of retrovirus-like particles. Western blot analysis of cell lysates showed significantly higher levels of expression when the BLV sequences were under the control of the synthetic late promoter in comparison with the VV P7.5 promoter. Our Western blot data also showed the absence of Pr44 processing into mature gag proteins in constructs expressing gag alone. When cells were infected with rVVs expressing the pro gene, Pr44 was efficiently cleaved into mature gag proteins and uncharacterized intermediates, demonstrating the expression of a biologically functional protease. Although the derivation and specificity of higher M r precursors remained obscure, the observed intermediates probably resulted from partial cleavage of Pr44. The observation that small amounts of the 30K to 31K intermediate also appeared in rVV-g-infected cells could be due to residual activity of the truncated protease or inefficient cleavage by another protease. A retroviral protease-like gene has been found in the VV genome (Slabaugh & Roseman, 1989) although it is not yet known whether this sequence encodes a protein with protease-like activities. However, it is of interest to note that Hu et al. (1990) also detected trace amounts of processing intermediates when expressing HIV sequences in CV-1 cells, independent of whether the rVVs used encoded a truncated HIV protease or no protease at all.
Western blot analysis of purified VLPs and sucrose density gradient fractionation of [35S]methionine-labelled VLPs revealed preferential appearance of mature gag proteins over processing intermediates of higher Mr in BLV-like particles. Furthermore these experiments clearly demonstrated that assembly and budding of VLPs was not dependent on expression of pro or the processing of the gag precursor. The immunoblot of purified VLPs in Fig. 2(b) and the radioactivity of recovered particles in Fig. 3 showed only minor differences in the budding efficiency of the different constructs. Reported studies with HIV similarly showed that expression of pro and processing of the gag precursor are not essential for VLP assembly and budding (Shioda & Shibuta, 1990; Hoshikawa et al., 1991) .
Because the VV expression system does not support the splicing of mRNA, a ribosomal frameshift appears to be the only possibility that allows expression of the BLV protease. Translation of the pol gene products would require a second ribosomal frameshift to read from all three reading frames. For the construction of our rVVs we used the plasmid pBLV-A1, containing an 8.26 kb EcoRI fragment of an Australian BLV isolate (Coulston et al., 1990) . In comparison with the Belgian BLV sequence published by Rice et al. (1985) , this sequence appears to have a deletion of one C residue at position 2202 (position 1994 of the Belgian isolate). This would lead to a stop codon at position 2259, upstream of the start of the pol open reading frame at position 2318 and the slippery sequence involved in the proposed ribosomal frameshift (Le et al., 1991; Nam et al., 1993; Jacks & Varmus, 1985) needed for the expression of the pol gene. Since this would make the ribosomal frameshift impossible we resequenced the region and our results showed an additional C residue. The insertion of this C residue allows readthrough to the stop codon downstream of the start of the pol open reading frame, which is in agreement with the Belgian sequence. Using the RTdetect kit, we showed that VLPs purified from supernatants of rVV-g/p/p-infected cell cultures contained active RT, which supports the proposed translation mechanism.
Thin-section electron microscopy analysis of infected cells and pelleted supernatants revealed that immature retrovirus-like particles formed and budded at the cell membrane when only gag was expressed by the rVV. Additional expression of pro (rVV-g/p and rVV-g/p/p) led to the processing of the gag precursor and to the formation and release Of VLPs with a mature core comparable to that of FLK cell-derived wild-type BLV. The specificity of the budding structures was confirmed by immunoelectron microscopy and compared to BLV derived from persistently infected FLK cells.
Although assembly and budding of VLPs did not require expression of pro and processing of gag, maturation of BLV-like particles was dependent upon gag processing. These findings are in agreement with results obtained with HIV-like particles (Karacostas et al., 1993; Krfiusslich et al., 1993) . Furthermore, these experiments showed that particle assembly occurred in the absence of env products and other BLV-specific proteins and that budding and particle maturation did not require copackaging of genomic viral RNA.
The ability to generate mature VLPs that incorporated fully functional RT demonstrated that the ribosomal frameshift mechanism required to translate from three different reading frames operates in VV-infected cells. This system therefore gtllows further studies to be conducted on this unique expression strategy. Studies involving particle formation and incorporation ofheterologous glycoproteins by means of coexpression or dual infections will allow investigation of the signals and membrane anchors and the role of the cytoplasmic tail for the BLV/HTLV subgroup.
